Remaining the industry’s leading forum for cell therapy analytical professionals, the 7th Cell Therapy Analytical Development Summit returns to aid you in demonstrating product safety, functionality, and quality before heading to market.

Covering early- to late-stage assay development, focus your learning and address your specific analytical needs with our refined two-track format. No matter where you are in the product development cycle, gain hands-on expertise from designing predictive potency assays, through to validating and transferring methods for late-phase trials.

Featuring first-hand case studies and experiences from Takeda, Bayer, Genentech, Adicet Bio, Quell Therapeutics, and the U.S. Pharmacopeia, seize the opportunity to benchmark against peers, exchange solutions to persistent challenges, and strengthen your analytical toolkit, to excel in an increasingly competitive cell therapy landscape.

View the event here.